Company / Interest Expense
ARDELYX, INC. Interest Expense History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$5.0M
FY2023
5-year range
$3.4M / $5.0M
FY2019-FY2023
Trend
+45.6%
vs FY2022
Sector context
#35 of 44
Health Care
What the data says
ARDELYX, INC.'s interest expense of $5M is lower than 80% of companies in the Health Care sector (FY2023). Interest Expense returned to growth in FY2023 after 3 years of decline, reaching $5M.
Based on SEC 10-K filings.
$5M in FY2023 with a 5-year CAGR of +7.0%.
Increased from $5M to $5M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 44This company $5.0M Sector average $291.0M
▼
-98.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2023, interest expense increased 45.6% year-over-year.
- Ranks #35 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $5.0M | +45.6% |
| FY2022 | $3.4M | -24.5% |
| FY2021 | $4.5M | -11.7% |
| FY2020 | $5.1M | -11.0% |
| FY2019 | $5.7M | +62.0% |
| FY2018 | $3.5M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026